Teva-Salbutamol Sterinebs P.F. · DIN 01926934 · 1mg/mL · Inh Sol- 2.5mL Pk
Limited Use — Reason for Use code 265, 266, 267, 268 requiredMarketed · checked 2026-09-19
StatusLimited Use — Reason for Use code 265, 266, 267, 268 required
Write on scriptLU code 265, 266, 267, 268 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 265, 266, 267, 268
Coverage limit:
For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
Reason for Use code 265
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 266
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 267
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 268
Patients who have previously used nebulizer therapy within the last 12 month period.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Teva-Salbutamol Sterinebs P.F. · DIN 01926934
Manufacturer: Teva Canada Limited; listing date 1996-10-01
Health Canada: Marketed since 2012-07-06 · brand TEVA-SALBUTAMOL STERINEBS P.F. · ATC R03AC02 SALBUTAMOL · form Solution · route Inhalation · ingredients SALBUTAMOL (SALBUTAMOL SULFATE) 1 MG/ML · company Teva canada limited · schedule Prescription
Teva-Salbutamol Sterinebs P.F.: Formulary list price $0.3617/unit (unit not stated in source; not the patient's cost)
Ministry pays: $0.3617 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13550 · Verify on the e-Formulary ↗ (DIN 01926934)
Source record
DIN 01926934: Teva-Salbutamol Sterinebs P.F.
Raw flags: sec12=Y, sec3=Y
Item: 121200048; group id 232; item number 0412; lccId 00040; manufacturer id TEV
Source form: Inh Sol- 2.5mL Pk; strength: 1mg/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.3617; ministry $0.3617
Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01926934
Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13550
Interchangeable products
PMS-Salbutamol · DIN 02208229 · $0.3617
Ventolin Nebules P.F. · DIN 02213419 · not recorded
Shortage status: not checked (no credentials)